EADV is a non-profit organisation whose vision is to be the premier European Dermato-Venereology Society, with the key aims of improving the quality of patient care, providing continuing medical education (CME) for all Dermato-Venereologists in Europe, and advocacy on behalf of the specialty and patients.
At the 28th EADV Congress an October 2019 study by La Paz Hospital, Madrid was presented which indicated that, “the severity of psoriasis is associated with the severity of non-alcoholic fatty liver disease (NAFLD).” [EurekaNews, Quote]
“psoriatic patients with NAFLD had a more severe elatographic hepatic damage if they had a higher level of psoriasis severity.” [EurekaNews, Quote]
The researchers said, "Previous research has already established a link between psoriasis and NAFLD. This is one of the first studies to assess the relationship between the severity of psoriasis with the severity of NAFLD,"
"In this context, increasing awareness and the continued assessment of the severity of NAFLD in patients with psoriasis by primary care physicians, specialists, health policy makers and patients, should be prioritized to help manage both conditions."
An Iranian study showed that, “the prevalence of NAFLD was high in patients with psoriasis and the severity of the NAFLD increased in high-grade psoriasis cases. Also, the severity of the NAFLD had a positive correlation with the grade of psoriasis, which is due to pro-inflammatory cytokines and adipocytokine. Cytokines trigger psoriasis and increase the severity of the disease.”
References & Citations
https://www.eurekalert.org/pub_releases/2019-10/sh-sop100719.php